Elizabeth A. Winzeler

Government of the United States of America — United States

Medicine · Health Sciences

82h-index35.9kcitations349works2.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Malaria Research and Control(197), Mosquito-borne diseases and control(72), Computational Drug Discovery Methods(59), HIV/AIDS drug development and treatment(45), Trypanosoma species research and implications(28)

Publications347 total

Author Correction: Diversity-oriented synthesis yields novel multistage antimalarial inhibitors
Nature·2025Open Access
Mechanistic insights into dual-active liver and blood-stage antiplasmodials
mBio·2025Open Access
Shared Binding Site but Divergent Resistance Profiles Uncover Novel Resistance Mechanisms in <i>Plasmodium</i> HSP90 Inhibitors
2025Open Access
Targeting Aurora Kinases as Essential Cell‐Cycle Regulators to Deliver Multi‐Stage Antimalarials Against <i>Plasmodium Falciparum</i>
Angewandte Chemie International Edition·2025· 1 citedOpen Access
Targeting Aurora Kinases as Essential Cell‐Cycle Regulators to Deliver Multi‐Stage Antimalarials Against <i>Plasmodium Falciparum</i>
Angewandte Chemie·2025Open Access
Collateral hypersensitivity between ZY19489 and piperaquine neutralizes PfCRT-mediated drug efflux and Plasmodium falciparum resistance
2025Open Access
Disruption of P. falciparum amino acid transporter elevates intracellular proline and induces resistance to Prolyl-tRNA synthetase inhibitors
Cell chemical biology·2025· 1 cited
Mechanistic Insights into Dual-Active Liver and Blood-Stage Antiplasmodials
2025Open Access
Exploration of Fluorinated Peptoid‐Based Histone Deacetylase Inhibitors as Dual‐Stage Antiplasmodial Agents
Archiv der Pharmazie·2025Open Access
The Human Chk1 Inhibitor CHIR-124 Shows Multistage Activity Against <i>Plasmodium falciparum</i> via Dual Inhibition of <i>Pf</i> Ark1 and Hemozoin Formation
2025· 3 citedOpen Access
Targeting Aurora kinases as essential cell cycle regulators to deliver multi-stage antimalarials against <i>Plasmodium falciparum</i>
2025· 2 citedOpen Access
Plasmodium falciparum protein kinase 6 and hemozoin formation are inhibited by a type II human kinase inhibitor exhibiting antimalarial activity
Cell chemical biology·2025· 3 citedOpen Access
Exploration of fluorinated peptoid-based histone deacetylase inhibitors as dual-stage antiplasmodial agents
2025Open Access
Inner-mitochondrial membrane protein <i>Pf</i>MPV17 is linked to <i>P. falciparum in vitro</i> resistance to the indoloquinolizidine alkaloid alstonine
Journal of Antimicrobial Chemotherapy·2025Open Access
In vivo screen of Plasmodium targets for mosquito-based malaria control
Nature·2025· 10 citedOpen Access
Exploration of fluorinated peptoid-based histone deacetylase inhibitors as dual-stage antiplasmodial agents
2025Open Access
Revisiting the Plasmodium falciparum druggable genome using predicted structures and data mining
npj Drug Discovery.·2025· 6 citedOpen Access
Fungal-derived methyldeoxaphomins target <i>Plasmodium falciparum</i> segregation through the inhibition of PfActin1
Proceedings of the National Academy of Sciences·2025· 1 citedOpen Access
&lt;b&gt;Plasma Lipid Metabolites, Clinical Glycemic Predictors and Incident Type 2 Diabetes&lt;/b&gt;
2025Open Access
&lt;b&gt;Plasma Lipid Metabolites, Clinical Glycemic Predictors and Incident Type 2 Diabetes&lt;/b&gt;
2025Open Access
page 1 of 18Next →

Frequent Co-authors

David Plouffe(18), Yingyao Zhou(14), David A. Fidock(13), Case W. McNamara(10), Stephan Meister(9), Ronald W. Davis(8), Lee M(8), Thierry T. Diagana(8), Dyann F. Wirth(8), Karine G. Le Roch(7), Matthias Rottmann(6), Nobutaka Kato(6), Kelli Kuhen(6), Arnab K. Chatterjee(6), Selina Bopp(6), David J. Lockhart(5), Bryan K. S. Yeung(5), Neekesh V. Dharia(5), Francisco‐Javier Gamo(5), A. S. Nagle(5)